NIH-funded research U01 cooperative agreement

Precision 3D imaging to monitor Kaposi sarcoma (KS) with SkinScan3D

Official title: PRecision IMaging to Evaluate Kaposi Sarcoma (PRIME-KS)

Funded at Washington University · NIH-11402685 · Data updated 2026-11-12

A new portable 3D imaging tool uses AI to measure KS skin lesions more quickly and objectively, helping people withKS and their clinicians track treatment.

More Sarcoma research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 7, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$478,526
NIH project number5U01CA292765-03
Project IDNIH-11402685 on NIH RePORTER

Who could benefit from this research

Could help

People with Kaposi sarcoma being treated or monitored at participating clinical sites.

Less likely to help

Patients in settings without access to the SkinScan3D device or where imaging cannot be performed may not benefit.

What this research studies

This project will test SkinScan3D, a low-cost 3D imaging system designed to capture lesion height and volume in KS. It uses liquid lens technology and artificial intelligence to provide precise measurements that could replace time-consuming manual assessments in clinics. The study will be conducted in high-need settings to see if the technology improves decision-making about therapy duration and intensity for patients with KS. Results will inform how KS patients in the U.S. and other regions could receive faster, more consistent monitoring. The effort is led by Washington University in Saint Louis, in collaboration with PensieVision, a U.S. company.

Why it matters

Potential benefit: If successful, patients with KS could receive more accurate and timely treatment decisions, potentially reducing unnecessary chemotherapy exposure.

How similar studies have gone: Prior imaging-guided monitoring initiatives have shown promise; this study applies a new 3D-AI approach to KS.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Odeny, Thomas — Washington University
  • Study coordinator: Odeny, Thomas

Related research

Other NIH-funded projects on the same topics.

  • Precision 3D Imaging to Monitor Kaposi Sarcoma (KS) with SkinScan3D

    A new portable 3D imaging tool called SkinScan3D will help doctors measure KS skin lesions more accurately and quickly, especially in people living with HIV.

    NIH research Washington University · Saint Louis, United States · NIH-11535366

  • Precision 3D Imaging to Track Kaposi Sarcoma (KS) with SkinScan3D

    A new 3D imaging tool called SkinScan3D helps doctors monitor Kaposi sarcoma lesions more accurately and quickly, especially in settings with high KS burden like East Africa and in U.S. clinics with HIV patients.

    NIH research Washington University · Saint Louis, United States · NIH-11535365

  • Kaposi Sarcoma care and research in Africa during ART era

    A collaborative program to better understand and improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV in Zambia and Tanzania.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11535231

  • Kaposi Sarcoma in Africa: ART Era Research Network

    A collaborative program in Africa and the United States will study Kaposi sarcoma in people living with HIV on ART to improve diagnosis, treatment, and prevention.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11535230

  • Kaposi Sarcoma in Africa in the ART Era

    This grant supports research to improve how Kaposi sarcoma is detected, treated, and understood in people living with HIV in Zambia and Tanzania during ART, with collaboration between African hospitals and a U.S. center.

    NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11417959

  • Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa

    This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11416376

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.